Sofinnova Raises €445m To Help European Biotechs Reach Critical Mass - And SPACs Are A Welcome Innovation

Funds To Fuel Maturing Firms

 
• By Andrew McConaghie
  
Paris
Paris is home to a growing number of biotech companies - but major funding is still hard to come by compared to the US.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business